- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: AUPH - Aurinia Pharmaceuticals
Posted on 1/24/18 at 1:39 pm to Wade Phillips
Posted on 1/24/18 at 1:39 pm to Wade Phillips
quote:Nothing has driven this rise to $6 but a return to normalcy after a tax driven sell off that started in November.
It seems this thing moves on good news then settles back down over time. Is it not still 12+ months away from any material breakthroughs driving revenue?
You gotta figure that "normal" for this stock is $6.50 to $7 due to the massive number of shares that were offered last April at $6.75, which at the time, seemed like a GREAT deal.
The only reason it dropped much lower than that (into the $5s) is because they announced that phase III wouldn't be completed until late 2019. People dumped, and then people who bought at $7,8,9,10 dumped to harvest a tax loss late in 2017.
As predicted, it's rising back to a reasonable price that correlates to a 500-600 million market cap, and it's doing it faster than I expected.
Always remember, the potential sales for Voclosporin is upwards of 3 billion dollars. A buyout would likely reflect that price plus a little extra. Not likely to happen in 2018 though.
Popular
Back to top
Follow TigerDroppings for LSU Football News